Abstract

Background

College freshmen living in dormitories are at increased risk for meningococcal disease. Many students become a high‐risk population when they travel to the United States. This study surveyed the knowledge, attitudes toward, and behavior surrounding the disease among Taiwanese college students planning to study in the United States, and to identify factors that may affect willingness to accept meningococcal vaccination.

Methods

A cross‐sectional survey of college students going to study in the United States was conducted in a medical center‐based travel medicine clinic. Background information, attitudes, general knowledge, preventive or postexposure management, and individual preventive practices were collected through a structured questionnaire.

Results

A total of 358 students were included in the final analysis. More than 90% of participants believed that preventing meningococcal disease was important. However, fewer than 50% of students accurately answered six of nine questions exploring knowledge of the disease, and only 17.3% of students knew the correct management strategy after close contact with patients. Logistic regression analysis showed that students who understood the mode of transmission (odds ratio: 3.21, 95% CI = 1.117–9.229), medication management (1.88, 1.045–3.38), and epidemiology (2.735, 1.478–5.061) tended to be vaccinated.

Conclusions

Despite an overall positive attitude toward meningococcal vaccination, there was poor knowledge about meningococcal disease. Promoting education on the mode of transmission, epidemiology, and pharmacological management of the disease could increase vaccination rates. Both the governments and travel medicine specialists should work together on developing an education program for this high‐risk group other than just requiring vaccination.

Despite advances in global efforts to develop new vaccines, invasive meningococcal disease remains a devastating disease with a fulminant course.1–8 The annual incidence was 0.33 cases per 100,000 population in 2007 and an estimated 1,525 cases of meningococcal disease occur annually in the United States.9 Because the incidence is highest among infants and adolescents, routine immunization from the ages of 11 to 19 years (especially between the ages of 11 and 12 years) is recommended by the Advisory Committee on Immunization Practices.10,11,12

College freshmen living in dormitories are at particularly high risk for developing meningococcal disease.13 Because of this, students from overseas who are planning to live in college dormitories are usually required to provide proof of meningococcal immunization in the United States and other countries such as the United Kingdom. Many Taiwanese students preparing to study in the United States are required to have the vaccination, which is not a routine immunization in Taiwan.14 In addition, the vaccine is available only at 12 Centers for Disease Control contracted hospitals due to the scarceness of the vaccine in Taiwan.

However, receiving vaccination without learning about the disease is not enough to assure prevention and patient‐level factors may influence immunization coverage. Furthermore, educating patients about the risk of contracting the disease and the importance of the vaccine should be an essential part of the physician–patient discussion about vaccination.

Thus far, few studies have investigated the awareness and attitudes toward meningococcal disease among high‐risk students. We designed a study to survey the knowledge, attitudes, and behaviors about the disease among Taiwanese students planning to study in the United States.

Methods

Study Design and Participants

A cross‐sectional questionnaire survey on Taiwanese college students planning to study in the United States was conducted in National Taiwan University Hospital in Taipei, a medical center‐based travel medicine clinic, from January 2009 to December 2010. The questionnaire and consent forms were distributed to all college‐age nonmedical students from different universities planning to study in the United States. All study procedures were approved by the ethical committee of the National Taiwan University Hospital.

Questionnaire Design

A self‐administered, single‐choice questionnaire surveyed the background information, attitudes toward, and knowledge about meningococcal disease. The questionnaire was based upon personal practice experiences and designed after a careful literature review. Excluding background information, the questionnaire included two questions about attitudes, five questions about general knowledge of the disease, four questions on preventive or postexposure management, and two questions on individual preventive practices. Five experts tested the content validity, while the face validity was tested by five college students.

Statistical Analysis

Data management and statistical analyses were performed using SPSS 11.0 software. Frequency distributions were used to describe the demographic data. Stepwise logistic regression analysis determined the relative values of the variables related to positive attitudes on receiving vaccines and willingness to perform individual preventive practices. A p‐value less than 0.05 was considered statistically significant.

Results

Questionnaires were given to 450 students, and complete information was collected from 358 (154 males and 204 females) after eliminating incomplete questionnaires (effective response rate: 80%). The mean age of the final study group was 24.9 years.

Attitudes and Individual Preventive Practices

Among the 358 students included in the analysis, 93% had prior knowledge of meningococcal disease; however, only 49.4% were aware there was a vaccine for the disease. Ninety‐six percent of students considered vaccination to be important and 91.3% thought receiving vaccination was reasonable when visiting an area where vaccination was recommended but not required. Although insurance does not cover the cost of meningococcal vaccination in Taiwan (the mean meningo vaccination price is 24.97 USD), 86.3% of students indicated that they would pay for vaccination, even if the vaccination were recommended but not required (Table 1).

Table 1

Demographic data, attitude, and practice survey

Items Number Percentage 
Gender   
Male 154 32.5 
Female 204 67.5 
Age (average = 24.88 years ; SD = 5.32) 
Has heard of meningitis? 
Yes 232 64.8 
No 126 35.2 
Has heard of meningococcal vaccines? 
Yes 177 49.4 
No 181 50.6 
Important to receive vaccines if required 
Yes 347 96.9 
No 11 3.1 
Important to receive vaccines if it is just recommended 
Yes 327 91.3 
No 31 8.7 
Cash for the vaccine if it is just recommended 
Yes 309 86.3 
No 49 13.7 
Will you seek more information on this issue? 
Yes 270 75.4 
No 88 24.6 
Items Number Percentage 
Gender   
Male 154 32.5 
Female 204 67.5 
Age (average = 24.88 years ; SD = 5.32) 
Has heard of meningitis? 
Yes 232 64.8 
No 126 35.2 
Has heard of meningococcal vaccines? 
Yes 177 49.4 
No 181 50.6 
Important to receive vaccines if required 
Yes 347 96.9 
No 11 3.1 
Important to receive vaccines if it is just recommended 
Yes 327 91.3 
No 31 8.7 
Cash for the vaccine if it is just recommended 
Yes 309 86.3 
No 49 13.7 
Will you seek more information on this issue? 
Yes 270 75.4 
No 88 24.6 

General Knowledge of Meningococcal Disease

On two questions about general knowledge of meningococcal disease, fewer than 50% of students answered correctly (Figure 1). For example, only 31.3% of students knew how the disease was transmitted, although approximately 70% were aware of the common symptoms of meningococcal diseases.

Figure 1

General meningococcal disease knowledge survey.

Questions and expected correct answers:

graphic
(a) What are the common symptoms of meningococcal meningitis? Answer: Headache, unconsciousness, fever.(b) What is the infectious agent for meningococcal disease? Answer: Bacteria.(c) In what way do you think meningococcal disease is transmitted? Answer: By respiratory droplets.(d) What is the lethal rate of meningococcal meningitis? Answer: Around 10%.(e) Which region has uniquely high risk for meningococcal disease? Answer: Sub‐Saharan Africa.

Figure 1

General meningococcal disease knowledge survey.

Questions and expected correct answers:

graphic
(a) What are the common symptoms of meningococcal meningitis? Answer: Headache, unconsciousness, fever.(b) What is the infectious agent for meningococcal disease? Answer: Bacteria.(c) In what way do you think meningococcal disease is transmitted? Answer: By respiratory droplets.(d) What is the lethal rate of meningococcal meningitis? Answer: Around 10%.(e) Which region has uniquely high risk for meningococcal disease? Answer: Sub‐Saharan Africa.

Preventive or Postexposure Management Knowledge

Figure 2 shows the items surveyed and percentages of accurate responses about preventive or postexposure management of meningococcal disease. Fewer than half of students could accurately answer all four questions about how the disease was managed, such as timing of the first vaccination or medical management. For one item, management after close contact, only 17.3% of the students responded correctly.

Figure 2

Preventive or postexposure management knowledge survey.

Questions and expected correct answers:(a) What is the suitable management after close contact with meningococcal meningitis patient? Answer: Consulting doctor for medication prophylaxis.(b) What is the meningococcal vaccine revaccination interval? Answer: 3 to 5 years.(c) When should you be vaccinated before travel for enough meningococcal disease protection? Answer: at least 10 days prior to travel.(d) Is there any medication treatment for meningococcal meningitis? Answer: Yes.

graphic

Figure 2

Preventive or postexposure management knowledge survey.

Questions and expected correct answers:(a) What is the suitable management after close contact with meningococcal meningitis patient? Answer: Consulting doctor for medication prophylaxis.(b) What is the meningococcal vaccine revaccination interval? Answer: 3 to 5 years.(c) When should you be vaccinated before travel for enough meningococcal disease protection? Answer: at least 10 days prior to travel.(d) Is there any medication treatment for meningococcal meningitis? Answer: Yes.

graphic

Important Predictive Variables of the Positive Attitudes and Preventive Practices

Results of stepwise logistic regression analysis revealed three statistically significant predicting variables on positive attitudes and willingness of receiving vaccination by cash (Table 2). The analysis showed that students had positive attitudes toward vaccines and were willing to receive vaccination if they understood the mode of transmission (odds ratio: 3.21, 95% CI = 1.117–9.229), medication management (1.88, 1.045–3.38), and epidemiology (2.735, 1.478–5.061).

Table 2

Significant predictive knowledge questionnaire items related to the attitude toward meningococcal vaccine

Predicting items β SE OR p‐value 95% CI of OR 
Important to receive the vaccine if it is only recommended 
Transmission mode 1.166 0.539 3.210 0.03 1.117–9.229 
Medication management 0.631 0.299 1.880 0.035 1.045–3.380 
Cash for the vaccine if it is just recommended 
Epidemiology 1.006 0.314 2.735 0.001 1.478–5.061 
Predicting items β SE OR p‐value 95% CI of OR 
Important to receive the vaccine if it is only recommended 
Transmission mode 1.166 0.539 3.210 0.03 1.117–9.229 
Medication management 0.631 0.299 1.880 0.035 1.045–3.380 
Cash for the vaccine if it is just recommended 
Epidemiology 1.006 0.314 2.735 0.001 1.478–5.061 

β = normalized beta coefficient; SE = standard error; OR = odds ratio; CI = confidence interval.

Discussion

To our knowledge, this is one of the first studies to investigate the knowledge and attitudes and practices toward meningococcal disease in a high‐risk group, and to explore factors that might increase the acceptance of vaccination. Furthermore, the students' poor knowledge of the disease but strongly positive beliefs toward the vaccine is a good indication that better education for this high‐risk group and efforts at prevention are worthwhile goals for the government and medical personnel.

The World Health Organization and the US Centers for Disease Control and Prevention recommend prompt antibiotic prophylaxis for persons with close contact with invasive meningococcal disease patients, but only 17.3% of students in this study understood this. This effective way to prevent further transmission of invasive meningococcal disease may become impossible under these circumstances. Poor knowledge of the disease, which threatens disease prevention, was also demonstrated by questions about the timing of the initial vaccination, or the time needed for antibody to develop after vaccination. If students believe they are protected quickly after vaccination, many could arrive at the United States with insufficient immunity against meningococcal disease, despite the fact that they had been vaccinated. Moreover, only about 30% of students understood the “transmission mode” and “infectious agents” of meningococcal disease. This lack of basic knowledge of meningococcal disease indicates that students are neither being alerted to the disease nor having enough information about when becoming a high‐risk group.

Increasing vaccination coverage is essential for effective infectious disease control, and understanding the patient factors influencing acceptance of vaccination would help both the government and medical professionals develop and institute strategies for disease prevention. The study demonstrated that knowledge of meningococcal disease, including transmission mode, epidemiology, and medication management, were independent factors that influenced willingness to be vaccinated against the disease. Thus, we should put more emphasis on these issues in public health programs or individual education courses. Moreover, previous similar study results helped Taiwan Centers for Disease Control design continuing education programs on dengue fever, yellow fever, and malaria prevention for health professionals.15 The results of this study might also provide a focus for training medical personnel and stimulate discussion of meningococcal disease prevention in travel medicine clinics.

There are some limitations to this study. First, the financial factors surrounding the vaccine, especially the cost, may affect willingness to be vaccinated, a factor that is not disclosed on the questionnaire. Second, only 80% of the students surveyed returned the completed questionnaires, and distributing the questionnaire to the students in a busy clinic setting might have influenced this effective response rate. Third, because the study was a cross‐sectional survey, designing a future follow‐up study that could show the effects of education about the disease and vaccination is strongly suggested. Fourth, since individual countries have their own unique disease epidemiology, vaccine strategies, and macro socioeconomic status, certain results of this study might need to be modified.

Enhancing education and knowledge of the public and health professionals is crucial for controlling vaccine‐preventable disease. Our study results showed that despite an overall positive attitude toward meningococcal vaccination, there was poor knowledge about meningococcal disease. Promoting education about the disease, especially the mode of transmission, along with the epidemiology and medical management of the disease, could increase vaccination rates and reduce risk. This kind of survey should be adopted in other countries, and certain results could provide new insights for disease prevention and future research focus. Both the governments and travel medicine specialists should work together on developing an education program for this high‐risk group other than just requiring vaccination.

We would like to thank Miss Chia‐Chi Yu for her assistance in this study. We also thank the Centers for Disease Control, Taiwan for kind research support (LA099077‐1).

Declaration of Interests

The authors state they have no conflicts of interest to declare.

References

1
Gossger
N
Snape
MD
Yu
LM
, et al.
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
.
JAMA
 
2012
;
307
:
573
582
.
2
Sow
SO
Okoko
BJ
Diallo
A
, et al.
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
.
N Engl J Med
 
2011
;
364
:
2293
2304
.
3
Snape
MD
Perrett
KP
Ford
KJ
, et al.
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial
.
JAMA
 
2008
;
299
:
173
184
.
4
Santolaya
ME
O'Ryan
ML
Valenzuela
MT
, et al.
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer‐blind, placebo‐controlled study
.
Lancet
 
2012
;
379
:
617
624
.
5
Claus
H
Jordens
MS
Kriz
P
, et al.
Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
.
Vaccine
 
2012
;
30
:
155
160
.
6
Harrison
LH
.
Epidemiological profile of meningococcal disease in the United States
.
Clin Infect Dis
 
2010
;
50
(
Suppl 2
):
S37
S44
.
7
Cramer
JP
Wilder‐Smith
A
.
Meningococcal disease in travelers: update on vaccine options
.
Curr Opin Infect Dis
 
2012
;
25
:
507
517
.
8
Wilder‐Smith
A
.
Meningococcal vaccines: a neglected topic in travel medicine?
Expert Rev Vaccines
 
2009
;
8
:
1343
1350
.
9
Cohn
AC
MacNeil
JR
Harrison
LH
, et al.
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease
.
Clin Infect Dis
 
2010
;
50
:
184
191
.
10
Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11–18 years with meningococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep 2007; 56:794–795.
11
Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep 2009; 58: 1042–1043.
12
Harrison
LH
Pelton
SI
Wilder‐Smith
A
, et al.
The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease
.
Vaccine
 
2011
;
29
:
3363
3371
.
13
Bruce
MG
Rosenstein
NE
Capparella
JM
, et al.
Risk factors for meningococcal disease in college students
.
JAMA
 
2001
;
286
:
688
693
.
14
Centers for Disease Control, R.O.C. (Taiwan), current immunization schedule. Available at: http://www.Cdc.Gov.Tw/english/list.Aspx?Treeid=e79c7a9e1e9b1cdf&nowtreeid=9aca97f87d31282d. (Accessed 2013 Jan 22).
15
Huang
HL
Chiu
TY
Huang
KC
, et al.
Travel‐related mosquito‐transmitted disease questionnaire survey among health professionals in Taiwan
.
J Travel Med
 
2011
;
18
:
34
38
.